BamSEC and AlphaSense Join Forces
Learn More

Cabaletta Bio Inc.

NASDAQ: CABA    
Share price (12/20/24): $2.38    
Market cap (12/20/24): $116 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.4
from 10-Q 6 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Second Amendment to Lease
12/34/56
EX-10.3
from 10-Q 5 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Service Agreement Amendment Amendment to Service Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Large Lab Client Customization Agreement
12/34/56
EX-10.1
from 10-Q 16 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Service Agreement 1
12/34/56
EX-10.1
from 10-Q 5 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Fourth Amendment Agreement
12/34/56
EX-10.1
from 10-Q 5 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Amendment Agreement
12/34/56
EX-10.19
from 10-K 3 pages Cabaletta Bio, Inc. Third Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.2
from 10-Q 6 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Amendment No. 5 to Sponsored Research Agreement
12/34/56
EX-10.1
from 10-Q 4 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential
12/34/56
EX-10.3
from 10-Q 3 pages Cabaletta Bio, Inc. Second Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.2
from 10-Q 3 pages Cabaletta Bio, Inc. 2929 Arch Street, Suite 600, Philadelphia, Pa 19104, USA Attention: CEO 27 March 2023 to Whom It May Concern Amendment to Licence and Supply Agreement 1. We Refer to the Licence and Supply Agreement Dated 30 December 2021 Entered Into Between Oxford Biomedica (Uk) Limited and Cabaletta Bio, Inc. (The “Licence Agreement”). Unless Expressly Defined Herein, Capitalised Terms Use in This Letter Shall Have the Meaning Set Out in the Licence Agreement. 2. We Hereby Agree That: A. Clause 12.3 Shall Be Deleted and Replaced With the Following (Whereby the Text in Bold Type Is an Addition to the Original Text)
12/34/56
EX-10.1
from 8-K 1 page Amendment No. 1 to the Cabaletta Bio, Inc. 2019 Stock Option and Incentive Plan
12/34/56
EX-10
from 10-Q 20 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Master Translational Research Services Agreement
12/34/56
EX-10
from 10-K 20 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Development, Manufacturing, and Testing Services Agreement
12/34/56
EX-10
from 10-K 4 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Amendment No. 4 to Sponsored Research Agreement
12/34/56
EX-10.1
from 10-Q 44 pages Exclusive License Agreement by and Between Cabaletta Bio, Inc. and Nanjing Iaso Biotherapeutics Co., Ltd
12/34/56
EX-10.31
from 10-K 61 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Oxford Biomedica (Uk) Limited and Cabaletta Bio, Inc. Licence and Supply Agreement Contents
12/34/56
EX-10.30
from 10-K 6 pages Option Agreement Terms and Conditions
12/34/56
EX-10.29
from 10-K 18 pages Certain Confidential Portions of This Exhibit Have Been Omitted and Replaced With “[***]”. Such Identified Information Has Been Excluded From This Exhibit Because It Is (I) Not Material and (II) the Type of Information That the Registrant Treats as Private or Confidential. Sponsored Research Agreement
12/34/56
EX-10.28
from 10-K 15 pages Employment Agreement
12/34/56